论文部分内容阅读
目的:观察沙美特罗替卡松吸入联合顺尔宁口服治疗儿童哮喘的临床疗效。方法:将112例小儿支气管哮喘患者随机分为两组,对照组56例采用沙美特罗替卡松吸入治疗,观察组56例在此基础上采用顺尔宁治疗,比较两组的临床疗效及对肺功能的影响。结果:两组总有效率比较,差异无统计学意义(P>0.05),而观察组显效率高于对照组(P<0.05)。治疗后两组FEV1、PEF水平均明显升高(P<0.05),并且观察组治疗后FEV1、PEF水平明显高于同期对照组(P<0.05)。结论:沙美特罗替卡松吸入联合顺尔宁口服治疗儿童哮喘,明显提高了临床治疗效果,改善了患儿肺功能,值得临床推广应用。
Objective: To observe the clinical efficacy of salmeterol and ticlazine inhalation combined with oral Salbutamol in the treatment of childhood asthma. Methods: One hundred and twelve cases of children with bronchial asthma were randomly divided into two groups. 56 cases in the control group were treated with salmeterol and fluticasone inhalation. 56 cases in the observation group were treated with sotalin. The clinical efficacy and Impact on lung function. Results: There was no significant difference in the total effective rate between the two groups (P> 0.05), while the effective rate of the observation group was higher than that of the control group (P <0.05). After treatment, the FEV1 and PEF levels in both groups were significantly increased (P <0.05), and the FEV1 and PEF levels in the observation group were significantly higher than those in the control group (P <0.05). Conclusion: Salmeterol and Tamsulosin inhalation combined with oral Salbutamol treatment of childhood asthma significantly improved the clinical treatment effect, improve the lung function in children, it is worthy of clinical promotion and application.